FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status
![]()
| Dockets Management |
||||||||||||
| Dockets Entered On August 26, 2003 Table of Contents |
||||||||||||
| Docket # |
Title |
|||||||||||
| 1997S-0162 30-Day Structure Function Claim Notification Letters Dietary 2003P-0387 21 CFR 10.30 to request that the Commissioner of Food and Drug take action described methodology for oral levothyroxine sodium drug products |
||||||||||||
| Contents |
||||||||||||
| |
1997S-0162 |
|
30-Day Structure Function Claim Notification Letters Dietary |
|||||||||
| PhytoPharmica Natural Medicines |
Vol #: |
81 |
||||||||||
| LeNature's , Inc. |
Vol #: |
81 |
||||||||||
| Enzymatic Therapy Natural Medicines |
Vol #: |
81 |
||||||||||
| Nutra Therapeutics International |
Vol #: |
81 |
||||||||||
| Pure Research Products naturally LLC |
Vol #: |
81 |
||||||||||
| Country Life |
Vol #: |
81 |
||||||||||
| Pharmanex |
Vol #: |
81 |
||||||||||
| Gaia Herbs |
Vol #: |
81 |
||||||||||
| Amarillo Biosciences, Inc. |
Vol #: |
81 |
||||||||||
| Weleda, Inc. |
Vol #: |
81 |
||||||||||
| PhytoPharmica Natural Medicines |
Vol #: |
81 |
||||||||||
| PhytoPharmica Natural Medicines |
Vol #: |
81 |
||||||||||
| PhytoPharmica Natural Medicines |
Vol #: |
81 |
||||||||||
| Enzymatic Therapy Natural Medicines |
Vol #: |
81 |
||||||||||
| NF Formulas, Inc. |
Vol #: |
81 |
||||||||||
| Tyler Encapsulations |
Vol #: |
81 |
||||||||||
| Solgar Vitamin and Herb |
Vol #: |
81 |
||||||||||
| General Vitamin Corporation |
Vol #: |
81 |
||||||||||
| Perrigo Company of South Carolina |
Vol #: |
81 |
||||||||||
| Perrigo Company of South Carolina |
Vol #: |
81 |
||||||||||
| Perrigo Company of South Carolina |
Vol #: |
81 |
||||||||||
| Perrigo Company of South Carolina |
Vol #: |
81 |
||||||||||
| Herbmax, Incorporated |
Vol #: |
81 |
||||||||||
| NBTY Inc. |
Vol #: |
81 |
||||||||||
| NOW Foods |
Vol #: |
81 |
||||||||||
| NOW Foods |
Vol #: |
81 |
||||||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
||||||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
||||||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
||||||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| DEE CEE Laboratories, Inc. |
Vol #: |
81 |
|||||||
| |
2003P-0387 |
|
21
CFR 10.30 to request that the Commissioner of Food and Drug take action
|
||||||
| HFA-305 to Abbott Laboratories |
Vol #: |
1 |
|||||||
| Abbott Laboratories |
Vol #: |
1 |
|||||||
Page updated September 8, 2003 jb